CIDRAP Leadership Forum Infectious Disease BRIEFING August 17, 2016

Similar documents

CIDRAP Leadership Forum Infectious Disease BRIEFING

CIDRAP Leadership Forum Infectious Disease BRIEFING

Corporate Leadership Forum March Briefing March 11, 2015

When infections go viral Zika Virus

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

VACCINES AND HYGIENE RULES

Outbreak preparedness and the NICD 24-hour hotline a review of calls made to the Hotline, and Outbreak Response Unit, July 2016-June 2017

Module 5: Introduction to Stochastic Epidemic Models with Inference

Module 5: Introduction to Stochastic Epidemic Models with Inference

Arbovirus Surveillance: Present and Future

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

Our Mission. To promote healthy and safe travel by providing medicines, preventive vaccines and health counseling to a diverse group of travelers

2/26/2018. Deadliest Enemy: Our War Against Killer Germs

EC research and innovation strategy and actions

Where is Yellow Fever found?

Classification of Infectious Disease Law in Japan

Financing international collective action for epidemic & pandemic preparedness

Preparing for the Unexpected

GAVI S VACCINE INVESTMENT STRATEGY

Duane J. Gubler, ScD Professor and Founding Director, Signature Research Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore

Arboviruses: A Global Public Health Threat

How does Gavi make vaccine investment decisions?

Experiences on Workforce Development in Other Regions

Progress report on emerging and re-emerging diseases including dengue and dengue haemorrhagic fever

Annual Epidemiological Report

What s new in Infectious Diseases. Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital

Understanding and Preparing for Emerging Disease Outbreaks

Partnerships for Vaccines Forum

WHO: Forum Issue #02 Student Officer Position:

INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day

Multiple Choice Questions

Mosquito-borne virus prevention and control: a global perspective

Emerging TTIs How Singapore secure its blood supply

Public health preparedness and response

Infectious Diseases Weekly Report. 12 January 2018 / Number 1. The infectious diseases which all physicians must report

Risk assessment group (RAG), between

UPDATE ON INFECTIOUS DISEASES 2015

Infectious Diseases Weekly Report. 23 August 2018 / Number 33. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 8 November 2018 / Number 44. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 15 November 2018 / Number 45. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 14 March 2019 / Number 10. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 22 March 2019 / Number 11. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 28 March 2019 / Number 12. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 4 April 2019 / Number 13. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 11 April 2019 / Number 14. The infectious diseases which all physicians must report

Downloaded from

Integrating Aedes Into Existing Malaria Vector Control Systems In Africa

Objectives: To share experiences and barriers to adult vaccination in Latin American countries

Prevention of arboviral diseases. Willem Takken & Sander Koenraadt Laboratory of Entomology Wageningen University and Research

Disease Prevention, Detection & Response During Public Health Emergencies

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS

UNDERSTANDING ZIKA AND MOSQUITO BORNE ILLNESSES

Emerging and Re-emerging Infectious Diseases and Major Factors Contributing to their Emergence

DIAGNOSTICS FOR EPIDEMIC PREPAREDNESS

The Potential Impacts of 21st Century Climatic and Population Changes on Human Exposure to the Virus Vector Mosquito Aedes aegypti

Preventing disease Promoting and protecting health

Report to the Board 6-7 June 2018

UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI

Health Information For International Travel, [Paperback] By The Centers for Disease Control and Prevention - CDC

Opportunities for the Future of Healthcare and Public Health Preparedness, Response, and Recovery

Inaugural Keynote Lecture: Contributions of Gavi and DCVMN to the global vaccine markets

Looking forward based on past experiences: What s old is new again

Preventing disease Promoting and protecting health

Demand forecasting and market considerations

CAA Meeting COMMUNICABLE DISEASE CONTROL. 20 July 2016

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

How and Why Vaccines are Made. Stanley A. Plotkin

Public Health Image Library. CDC/ Cynthia Goldsmith. Image #

Lessons of Disease Eradication Efforts for Invasive Mussel Control. Jim Koopman MD MPH, Professor Emeritus

lated at the 6 regions/zobas before emerging disease include epidemic prone diseases

A conversation with Michael Osterholm on July 30, 2013 about pandemics

Waiting in the Wings: Emergence, Impact and Control of Mosquito-Borne Viruses

Annual Summary of Reportable Diseases Ottawa County 2017

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA

Health care workers and infectious diseases

Combating Agent X: Accelerating Global Vaccine Production Against New Pandemic Threats

BOVA Network - Building Out Vector-borne diseases in sub-saharan Africa. First BOVA Open Network Meeting IEDE-UCL, London, 28 th March 2018

For Week 38 of 2015 (Week ending 20 September, 2015)

Mosquito Control Update. Board of County Commissioners Work Session February 16, 2016

Zika virus infection Interim clinical guidance for Primary Care

Module Three About Zika Virus: What is Known and Not Known

Keynote Address: The Challenge of Achieving Universal Access to Vaccines

ZIKA VIRUS. John J. Russell MD May 27, 2016

Create the Following Chart in your notebook. Fill in as you go through each one.

1966 CDC assessment of US Health

Mercer MRC A Newsletter for and about our volunteers

Zika Virus Update. Florida Department of Health (DOH) Mark Lander. June 16, Florida Department of Health in Columbia County

SCIENTIFIC STUDY GROUP ON TRAVEL MEDICINE NATIONAL CONSENSUS MEETING 2018

ZIKA: is South Africa at risk? Lucille Blumberg National Institute for Communicable Diseases South Africa

The Zika Crisis: Where, What and USG/WHO? Brian R. Moyer BRMoyer & Associates, LLC Bedford, NH

Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

Thank you to our 2018 HHL Conference Sponsors!

Zika Virus Infections Perspectives Past, Present and Future

CHAPTER AT A GLANCE. Science Class (SA-II)- IX

Emerging & re-emerging infections on the African Continent-the Public Health Aspect: Is Africa Prepared?

Global Health & Disasters Course

WHO Emergency Committees

Republic of Sierra Leone

Transcription:

Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING August 17, 2016

CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya, Dengue, Malaria Zika + Yellow Fever Vaccines 2. Polio 3. Influenza 4. Antibiotic resistance MCR-1, ASP landing page 5. Anthrax 6. Ebola + vaccine 7. CEPI - Coalition for Epidemic Preparedness and Innovation 8. MERS-CoV 9. Other Cyclospora infections, Guinea worm

CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya, Dengue, Malaria Zika + Yellow Fever Vaccines 2. Polio 3. Influenza 4. Antibiotic resistance MCR-1, ASP landing page 5. Anthrax 6. Ebola + vaccine 7. CEPI - Coalition for Epidemic Preparedness and Innovation 8. MERS-CoV 9. Other Cyclospora infections, Guinea worm

Aedes aegypti

Aedes aegypti Distribution in the Americas 1930's 1970 2015 Adapted from Gubler, 1998

CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya, Dengue, Malaria Zika + Yellow Fever Vaccines 2. Polio 3. Influenza 4. Antibiotic resistance MCR-1, ASP landing page 5. Anthrax 6. Ebola + vaccine 7. CEPI - Coalition for Epidemic Preparedness and Innovation 8. MERS-CoV 9. Other Cyclospora infections, Guinea worm

CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya, Dengue, Malaria Zika + Yellow Fever Vaccines 2. Polio 3. Influenza 4. Antibiotic resistance MCR-1, ASP landing page 5. Anthrax 6. Ebola + vaccine 7. CEPI - Coalition for Epidemic Preparedness and Innovation 8. MERS-CoV 9. Other Cyclospora infections, Guinea worm

CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya, Dengue, Malaria Zika + Yellow Fever Vaccines 2. Polio 3. Influenza 4. Antibiotic resistance MCR-1, ASP landing page 5. Anthrax 6. Ebola + vaccine 7. CEPI - Coalition for Epidemic Preparedness and Innovation 8. MERS-CoV 9. Other Cyclospora infections, Guinea worm

CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya, Dengue, Malaria Zika + Yellow Fever Vaccines 2. Polio 3. Influenza 4. Antibiotic resistance MCR-1, ASP landing page 5. Anthrax 6. Ebola + vaccine 7. CEPI - Coalition for Epidemic Preparedness and Innovation 8. MERS-CoV 9. Other Cyclospora infections, Guinea worm

CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya, Dengue, Malaria Zika + Yellow Fever Vaccines 2. Polio 3. Influenza 4. Antibiotic resistance MCR-1, ASP landing page 5. Anthrax 6. Ebola + vaccine 7. CEPI - Coalition for Epidemic Preparedness and Innovation 8. MERS-CoV 9. Other Cyclospora infections, Guinea worm

CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya, Dengue, Malaria Zika + Yellow Fever Vaccines 2. Polio 3. Influenza 4. Antibiotic resistance MCR-1, ASP landing page 5. Anthrax 6. Ebola + vaccine 7. CEPI - Coalition for Epidemic Preparedness and Innovation 8. MERS-CoV 9. Other Cyclospora infections, Guinea worm

CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya, Dengue, Malaria Zika + Yellow Fever Vaccines 2. Polio 3. Influenza 4. Antibiotic resistance MCR-1, ASP landing page 5. Anthrax 6. Ebola + vaccine 7. CEPI - Coalition for Epidemic Preparedness and Innovation 8. MERS-CoV 9. Other Cyclospora infections, Guinea worm

CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya, Dengue, Malaria Zika + Yellow Fever Vaccines 2. Polio 3. Influenza 4. Antibiotic resistance MCR-1, ASP landing page 5. Anthrax 6. Ebola + vaccine 7. CEPI - Coalition for Epidemic Preparedness Innovation 8. MERS-CoV 9. Other Cyclospora infections

CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya, Dengue, Malaria Zika + Yellow Fever Vaccines 2. Polio 3. Influenza 4. Antibiotic resistance MCR-1, ASP landing page 5. Anthrax 6. Ebola + vaccine 7. CEPI - Coalition for Epidemic Preparedness and Innovation 8. MERS-CoV 9. Other Cyclospora infections, Guinea worm

CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya, Dengue, Malaria Zika + Yellow Fever Vaccines 2. Polio 3. Influenza 4. Antibiotic resistance MCR-1, ASP landing page 5. Anthrax 6. Ebola + vaccine 7. CEPI - Coalition for Epidemic Preparedness and Innovation 8. MERS-CoV 9. Other Cyclospora infections, Guinea worm

Questions, Comments and Discussion

Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING August 17, 2016 Thank you for attending!